The largest database of trusted experimental protocols

3h colchicine

Manufactured by PerkinElmer
Sourced in United States

[3H]colchicine is a radiolabeled compound used in scientific research. It is a derivative of the natural compound colchicine, with a tritium (3H) label incorporated into its structure. This product is commonly utilized in various experimental applications, such as binding studies and cell biology research, where the radioactive signal can provide valuable insights.

Automatically generated - may contain errors

7 protocols using 3h colchicine

1

Colchicine Binding Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inhibition of [3H]colchicine binding to tubulin was measured in 0.1 mL reaction mixtures, each containing 1.0 µM tubulin, 5.0 µM [3H]colchicine (Perkin-Elmer), 5% (v/v) dimethyl sulfoxide, compounds at 1.0 or 5.0 µM, as indicated, and components that stabilize the colchicine binding activity of tubulin (1.0 M monosodium glutamate [adjusted to pH 6.6 with HCl in a 2.0 M stock solution], 0.5 mg/mL bovine serum albumin, 0.1 M glucose-1-phosphate, 1.0 mM MgCl2, and 1.0 mM GTP). Incubation was for 10 min at 37 °C, when in control reaction mixtures colchicine binding is 40–60% complete. Reactions were stopped with 2.0 mL of ice-cold water, with the reaction mixtures being placed on ice. Each diluted sample was poured onto a stack of two DEAE-cellulose filters (GE Biomedical), followed by 3 successive 2 mL aliquots of ice-cold water. A reduced vacuum was used to remove excess water from the filters, which were washed three times with 2 mL water and placed into vials containing 5 mL of Biosafe II scintillation cocktail. Samples were counted 18 h later in a Beckman scintillation counter. Samples with inhibitors were compared to samples with no inhibitor, and percent inhibition was determined, correcting all values for the amount of radiolabel bound to the filters in the absence of tubulin.
+ Open protocol
+ Expand
2

Colchicine Binding Site Assay of G-1 in Tubulin

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ability of G-1 binding to the colchicine binding site in tubulin was examined using a CytoDYNAMIX screen 15 assay kit (Cytoskeleton Inc., Denver, CO, USA) in accordance with manufacturer’s instruction and previous description. Biotin-labeled tubulin (0.5 μg) in 10 μL of reaction buffer was mixed with [3H]colchicine (0.08 μM, PerkinElmer, Waltham, MA) and the test compounds (positive control colchicine, negative control vinblastine, G-1, fluorescent G-1, or 2-ME) in a 96-well plate (final volume: 100 μL). After incubating for 2 h at 37 °C with gentle shaking, streptavidin-labeled yttrium SPA beads (80 μg in 20 μL reaction buffer, PerkinElmer, Waltham, MA) were added to each well and incubated for 30 min at 4 °C. The radioactivity was determined using Packard TopCount Microplate Scintillation Counter (Packard Instrument, Meriden, CT, USA).
+ Open protocol
+ Expand
3

Chemotherapeutic agents and cytoskeleton

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nocodazole, paclitaxel (Taxol), vinblastine, and colchicine were purchased from Sigma-Aldrich (St. Louis, MO). SRF was purchased from ChemDiv while SB203580, PD98059 and SP600125 were from Calbiochem (San Diego, CA). Antibodies were obtained from the following companies: vimentin, α- and β-tubulin, JNK-1, Mdr-1, Bcl-2, pBcl-2 (T56), pBcl-2 (S70), pBcl-2 (S87) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA); pp38, pERK1/2, pJNK (Cell Signaling Technology, Denver, MA); monoclonal anti P-glycoprotein (MDR) (Sigma, USA) and monoclonal actin antibodies were from BD Pharmingen (San Diego, CA). [3H]vinblastine (specific activity, 11.6 Ci/mmol) and streptavidin-coated yttrium silicate scintillation proximity assay (SPA) beads were purchased from GE Healthcare (Buckinghamshire, UK). [3H]colchicine (specific activity, 80.4 Ci/mmol) was obtained from PerkinElmer (Boston, MA, USA).
+ Open protocol
+ Expand
4

Colchicine Site Competitive Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 6

The affinity of compounds 8c to colchicine binding site was determined using colchicine Site Competitive Assay kit CytoDYNAMIX Screen15 (Cytoskeleton, Inc., CO, USA) using the standard protocol of the manufacturer to determine Ki values (μM). Biotin-labelled tubulin (0.5 g) in 10 μL of reaction buffer was mixed with [3H]colchicine (0.08 μM, PerkinElmer, Waltham, Mass.) and the test compounds (positive control colchicine, negative control vinblastine, G-1, fluorescent G-1, or 2-ME) in a 96-well plate (final volume: 100 μL). After incubating for 2 h at 37° C. with gentle shaking, streptavidin-labelled yttrium SPA beads (80 g in 20 μL reaction buffer, PerkinElmer, Waltham, Mass.) were added to each well and incubated for 30 min at 4° C. The plates were then read on a scintillation counter (Packard Instrument, Topcount Microplate Reader) and the percentage of inhibition was calculated [54]

+ Open protocol
+ Expand
5

Benzotriazole Compounds Colchicine Site Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The affinity of Benzotriazole compounds to colchicine binding site was determined using a colchicine Site Competitive Assay kit CytoDYNAMIX Screen15 (Cytoskeleton, Inc., Denver, CO, USA) using the standard protocol of the manufacturer to determine Ki values (μM). Biotin-labelled tubulin (0.5 μg) in 10 μL of reaction buffer was mixed with [3H]colchicine (0.08 μM, PerkinElmer, Waltham, MA) and the test compounds (positive control colchicine, negative control vinblastine, G-1, fluorescent G-1, or 2-ME) in a 96-well plate (final volume: 100 μL). After incubating for 2 h at 37 °C with gentle shaking, streptavidin-labelled yttrium SPA beads (80 μg in 20 μL reaction buffer, PerkinElmer, Waltham, MA) were added to each well and incubated for 30 min at 4 °C. The plates were then read on a scintillation counter (Packard Instrument, Topcount Microplate Reader) and the percentage of inhibition was calculated [55 (link),56 (link)].
+ Open protocol
+ Expand
6

Colchicine Site Competitive Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 6

The affinity of compounds 8c to colchicine binding site was determined using colchicine Site Competitive Assay kit CytoDYNAMIX Screen15 (Cytoskeleton, Inc., CO, USA) using the standard protocol of the manufacturer to determine Ki values (μM). Biotin-labelled tubulin (0.5 μg) in 10 μL of reaction buffer was mixed with [3H]colchicine (0.08 μM, PerkinElmer, Waltham, Mass.) and the test compounds (positive control colchicine, negative control vinblastine, G-1, fluorescent G-1, or 2-ME) in a 96-well plate (final volume: 100 μL). After incubating for 2 h at 37° C. with gentle shaking, streptavidin-labelled yttrium SPA beads (80 μg in 20 μL reaction buffer, PerkinElmer, Waltham, Mass.) were added to each well and incubated for 30 min at 4° C. The plates were then read on a scintillation counter (Packard Instrument, Topcount Microplate Reader) and the percentage of inhibition was calculated [54]

+ Open protocol
+ Expand
7

Colchicine Site Binding Assay of Compound 12c

Check if the same lab product or an alternative is used in the 5 most similar protocols
The affinity of compounds 12c to colchicine binding site was determined using colchicine Site Competitive Assay kit CytoDYNAMIX Screen15 (Cytoskeleton, Inc., Denver, CO, USA) using the standard protocol of the manufacturer to determine Ki. Biotin-labelled tubulin (0.5 µg) in 10 µL of reaction buffer was mixed with [3H]colchicine (0.08 µM, PerkinElmer, Waltham, MA) and the test compounds (positive control colchicine, negative control vinblastine, G-1, fluorescent G-1, or 2-ME) in a 96-well plate (final volume: 100 µL). After incubating for 2 h at 37 °C with gentle shaking, streptavidin-labelled yttrium SPA beads (80 µg in 20 µL reaction buffer, PerkinElmer, Waltham, MA) were added to each well and incubated for 30 min at 4 °C. The plates were then read on a scintillation counter (Packard Instrument, Topcount Microplate Reader) and the percentage of inhibition was calculated50 (link),51 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!